Literature DB >> 7905930

Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer.

A A Sandberg1, C S Berger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7905930     DOI： 10.1016/s0022-5347(17)35014-0

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  23 in total

1.  Urothelial tumor initiation requires deregulation of multiple signaling pathways: implications in target-based therapies.

Authors:  Haiping Zhou; Hong-ying Huang; Ellen Shapiro; Herbert Lepor; William C Huang; Moosa Mohammadi; Ian Mohr; Moon-shong Tang; Chuanshu Huang; Xue-ru Wu
Journal:  Carcinogenesis       Date:  2012-01-27       Impact factor: 4.944

2.  Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells.

Authors:  Edmund Chiong; I-Ling Lee; Ali Dadbin; Anita L Sabichi; Loleta Harris; Diana Urbauer; David J McConkey; Rian J Dickstein; Tiewei Cheng; H Barton Grossman
Journal:  Clin Cancer Res       Date:  2011-03-17       Impact factor: 12.531

Review 3.  Genetics of bladder cancer.

Authors:  K K Saran; D Gould; C J Godec; R S Verma
Journal:  J Mol Med (Berl)       Date:  1996-08       Impact factor: 4.599

4.  Targeting gene expression of the mouse uroplakin II promoter to human bladder cells.

Authors:  Hongjian Zhu; Zhiqing A Zhang; Chunxiao Xu; Guojin Huang; Xiangfu Zeng; Shoushun Wei; Zhiwen Zhang; Yinglu Guo
Journal:  Urol Res       Date:  2003-02-18

5.  The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine.

Authors:  I A Sokolova; K C Halling; R B Jenkins; H M Burkhardt; R G Meyer; S A Seelig; W King
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

6.  Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Authors:  Markus Riester; Lillian Werner; Joaquim Bellmunt; Shamini Selvarajah; Elizabeth A Guancial; Barbara A Weir; Edward C Stack; Rachel S Park; Robert O'Brien; Fabio A B Schutz; Toni K Choueiri; Sabina Signoretti; Josep Lloreta; Luigi Marchionni; Enrique Gallardo; Federico Rojo; Denise I Garcia; Yvonne Chekaluk; David J Kwiatkowski; Bernard H Bochner; William C Hahn; Azra H Ligon; Justine A Barletta; Massimo Loda; David M Berman; Philip W Kantoff; Franziska Michor; Jonathan E Rosenberg
Journal:  Clin Cancer Res       Date:  2014-01-31       Impact factor: 12.531

7.  Prognostic significance of p53 protein accumulation in stage pT1 transitional cell carcinoma of the bladder.

Authors:  G Toktaş; L N Türkeri; E Unlüer; F Atuğ; C Murat; B Ozveren; M Calişkan; A Akdaş
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

8.  Isolation and characterization of a novel bladder cancer cell line: inhibition by epidermal growth factor.

Authors:  H Pratsinis; A Saetta; S Gagos; P Davaris
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

Review 9.  Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target.

Authors:  J P Crew; T S O'Brien; A L Harris
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

10.  Denovo urothelial carcinoma of the upper and lower urinary tract in kidney--transplant patients with end-stage analgesic nephropathy.

Authors:  W F Thon; V Kliem; M C Truss; P Anton; M Kuczyk; C G Stief; R Brunkhorst
Journal:  World J Urol       Date:  1995       Impact factor: 4.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.